Results 21 to 30 of about 71,600 (234)

Interspecies and Intrastrain Interplay among Leishmania spp. Parasites

open access: yesMicroorganisms, 2022
Leishmania parasites present astonishing adaptative abilities that represent a matter of life or death within disparate environments during the heteroxenous parasite life cycle.
Bruna Dias das Chagas   +6 more
doaj   +1 more source

Leishmaniasis

open access: yesIndian Journal of Critical Care Medicine, 2021
Leishmaniasis is one of the chronic debilitating vector-borne diseases caused by obligate intracellular protozoa. The global burden of disease although not increasing but potential risk of spread is there. At least 20 species of Leishmania are pathogenic to human beings. The transmission is from female sandfly through a blood meal.
Daga, Mradul K   +2 more
openaire   +3 more sources

Leishmania (Viannia) naiffi Lainson & Shaw 1989

open access: yesParasites & Vectors, 2023
Just over 30 years ago, a new species of Leishmania of the subgenus Leishmania (Viannia) was described infecting the armadillo Dasypus novemcinctus; then, a report of human infection followed.
Lilian Motta Cantanhêde   +1 more
doaj   +1 more source

Determinants of Unresponsiveness to Treatment in Cutaneous Leishmaniasis: A Focus on Anthroponotic Form Due to Leishmania tropica

open access: yesFrontiers in Microbiology, 2021
Cutaneous leishmaniasis (CL) is a curable disease; however, due to various risk factors, unresponsiveness to CL treatments is inevitable. The treatment of CL has been firmly correlated with multiple determinants, such as demographical, clinical, and ...
Mehdi Bamorovat   +4 more
doaj   +1 more source

Exploring Host-Specificity: Untangling the Relationship between Leishmania (Viannia) Species and Its Endosymbiont Leishmania RNA Virus 1

open access: yesMicroorganisms, 2023
A relevant aspect in the epidemiology of Tegumentary Leishmaniasis (TL) are the Leishmania parasites carrying a viral endosymbiont, Leishmania RNA Virus 1 (LRV1), a dsRNA virus.
Mayara Cristhine de Oliveira Santana   +3 more
doaj   +1 more source

Unusual clinical presentation of cutaneous leishmaniasis in a patient with corticosteroid‐induced immunosuppression

open access: yesClinical Case Reports, 2021
Clinicians should always consider rare, atypical, and opportunistic infections in patients undergoing long‐term systemic corticosteroid therapy. Diagnosis needs further evaluations and special consideration.
Maryam Mahdavi   +4 more
doaj   +1 more source

Leishmaniasis [PDF]

open access: yesPostgraduate Medical Journal, 2006
Abstract Epidemiology, disease patterns, immunology, diagnosis, treatment and control measures of leishmaniasis are described. Various issues relating to leishmaniasis are highlighted: the relative lack of importance given to this disease is compared with other infections, climate change and its possible effect on extension of endemicity
Tonio V, Piscopo   +1 more
openaire   +4 more sources

Insights from mathematical modelling and quantitative analysis on the proposed WHO 2030 targets for visceral leishmaniasis on the Indian subcontinent [version 1; peer review: 2 approved]

open access: yesGates Open Research, 2019
Visceral leishmaniasis (VL) is a neglected tropical disease (NTD) caused by Leishmania protozoa that are transmitted by female sand flies. On the Indian subcontinent (ISC), VL is targeted by the World Health Organization (WHO) for elimination as a public
NTD Modelling Consortium Visceral Leishmaniasis Group
doaj   +1 more source

Evaluation of a new live recombinant vaccine against cutaneous leishmaniasis in BALB/c mice

open access: yesParasites & Vectors, 2020
Background Leishmaniasis is a serious health problem in some parts of the world. In spite of the many known leishmaniasis control measures, the disease has continued to increase in endemic areas, and no effective vaccine has been discovered.
Samira Salari   +3 more
doaj   +1 more source

Post-Kala-Azar Dermal Leishmaniasis: A Paradigm of Paradoxical Immune Reconstitution Syndrome in Non-HIV/AIDS Patients

open access: yesJournal of Tropical Medicine, 2013
Visceral leishmaniasis (VL) is a parasitic disease characterized by immune suppression. Successful treatment is usually followed by immune reconstitution and a dermatosis called post-Kala-azar dermal leishmaniasis (PKDL).
Eltahir Awad Gasim Khalil   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy